| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 703037 | Null | 0.0228801759885691 | -0.20123533 |
| NSC 703117 | Null | 0.0228801759885691 | 0.54516213 |
| NSC 703544 | Null | 0.0228801759885691 | 0.38333916 |
| NSC 707904 | Null | 0.0228801759885691 | 0.53272094 |
| NSC 709483 | Null | 0.0228801759885691 | 0.47110103 |
| NSC 723548 | Null | 0.0228801759885691 | 0.59264136 |
| NSC 723732 | 8-{4-[6-(4-flurophenyl)-2-methyl-4-pyrimidinyloxy]butoxy}-7- methoxy-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a ][1,4]diazepin-5-one | 0.0228801759885691 | 0.43552409 |
| NSC 727087 | 16-[4-(2-diethylaminoethoxy)3-methoxy benzylidene]-17-oxo-5-androsten-3a-yl acetate | 0.0228801759885691 | 0.32786784 |
| NSC 728038 | 2[(3,4-dicloro)benzylamino]-3-phenyl-5,7-diamino quinoxaline | 0.0228801759885691 | 0.57835417 |
| NSC 730868 | (+)-(2R,3R)-6-{4-[(3-hydroxymethyl)oxiran-2-yl]buta-1,3-diyn yl}-2H-pyran-2-one | 0.0228801759885691 | 0.4847774 |